Phlow

In The CDMO X-Factor,Andrew Carpenter, Ph.D, a leader in cGMP manufacturing of small molecule APIs, with a passion for continuous manufacturing, will challenge the boundaries of what the industry once believed possible for advanced pharmaceutical ingredients manufacturing. This engaging session will include strategies that pharmaceutical companies can take to leverage effective partnerships with next-gen CDMOs, with in-house scientific expertise and state-of-the-art facilities, capable of deploying both continuous and batch manufacturing proven to drive down cost and reduce environmental impact. Learn how a creative relationship with a next-gen CDMO partner can help you develop and scale your pharmaceutical products in the United States more cost effectively. Learn what factors today can reduce production costs, increase quality, and lower environmental impact tomorrow. Explore extensive manufacturing capabilities, that will take your project from route scouting, process development to scale-up and commercial production, for your life-changing medicines.